Bridgeway Capital Management, LLC Enanta Pharmaceuticals Inc Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $1.74 Million - $2.25 Million	-26,600 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $239,287 - $353,836	2,800 Added 11.76%	26,600 $2.27 Million
Q2 2018 Aug 14, 2018	BUY	$81.85 - $120.51 $49,110 - $72,306	600 Added 2.59%	23,800 $2.76 Million
Q1 2018 May 15, 2018	SELL	$57.91 - $92.15 $14,477 - $23,037	-250 Reduced 1.07%	23,200 $1.88 Million
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $1.07 Million - $1.39 Million	23,450	23,450 $1.38 Million

21.2M

10.4K

2.3K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $236M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.